Glaukos Net Profit Margin 2014-2024 | GKOS
Current and historical net profit margin for Glaukos (GKOS) from 2014 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Glaukos net profit margin for the three months ending December 31, 2024 was .
| Glaukos Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-12-31 | $0.38B | $-0.15B | -38.28% |
| 2024-09-30 | $0.36B | $-0.15B | -41.55% |
| 2024-06-30 | $0.34B | $-0.16B | -46.49% |
| 2024-03-31 | $0.33B | $-0.14B | -43.25% |
| 2023-12-31 | $0.31B | $-0.14B | -42.99% |
| 2023-09-30 | $0.30B | $-0.13B | -42.57% |
| 2023-06-30 | $0.30B | $-0.13B | -42.91% |
| 2023-03-31 | $0.29B | $-0.14B | -48.44% |
| 2022-12-31 | $0.28B | $-0.10B | -35.34% |
| 2022-09-30 | $0.29B | $-0.09B | -31.93% |
| 2022-06-30 | $0.29B | $-0.06B | -19.72% |
| 2022-03-31 | $0.29B | $-0.03B | -9.52% |
| 2021-12-31 | $0.29B | $-0.05B | -16.67% |
| 2021-09-30 | $0.29B | $-0.04B | -12.93% |
| 2021-06-30 | $0.28B | $-0.06B | -21.13% |
| 2021-03-31 | $0.24B | $-0.08B | -34.87% |
| 2020-12-31 | $0.23B | $-0.12B | -53.78% |
| 2020-09-30 | $0.22B | $-0.07B | -33.49% |
| 2020-06-30 | $0.21B | $-0.07B | -33.49% |
| 2020-03-31 | $0.24B | $-0.04B | -15.48% |
| 2019-12-31 | $0.24B | $0.02B | 6.72% |
| 2019-09-30 | $0.23B | $-0.02B | -8.41% |
| 2019-06-30 | $0.21B | $-0.01B | -5.69% |
| 2019-03-31 | $0.20B | $-0.01B | -5.64% |
| 2018-12-31 | $0.18B | $-0.01B | -7.18% |
| 2018-09-30 | $0.17B | $-0.01B | -8.28% |
| 2018-06-30 | $0.17B | $-0.01B | -3.64% |
| 2018-03-31 | $0.16B | $0.00B | -2.45% |
| 2017-12-31 | $0.16B | 0 | 0.00% |
| 2017-09-30 | $0.15B | $0.00B | -0.67% |
| 2017-06-30 | $0.14B | $0.00B | -0.71% |
| 2017-03-31 | $0.13B | $0.00B | 3.13% |
| 2016-12-31 | $0.12B | $0.00B | 3.48% |
| 2016-09-30 | $0.10B | $0.00B | 1.96% |
| 2016-06-30 | $0.09B | $0.00B | -1.10% |
| 2016-03-31 | $0.08B | $-0.04B | -43.75% |
| 2015-12-31 | $0.07B | $-0.04B | -51.39% |
| 2015-09-30 | $0.07B | $-0.04B | -60.61% |
| 2015-06-30 | $0.06B | $-0.04B | -66.10% |
| 2015-03-31 | $0.05B | $-0.01B | -17.31% |
| 2014-12-31 | $0.05B | $-0.01B | -26.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.232B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $202.843B | 88.85 |
| Thermo Fisher Scientific (TMO) | United States | $153.281B | 18.54 |
| Edwards Lifesciences (EW) | United States | $45.022B | 29.52 |
| Alcon (ALC) | Switzerland | $43.031B | 29.08 |
| IDEXX Laboratories (IDXX) | United States | $40.969B | 47.08 |
| DexCom (DXCM) | United States | $33.925B | 52.44 |
| IQVIA Holdings (IQV) | United States | $24.535B | 13.74 |
| Mettler-Toledo (MTD) | United States | $23.231B | 27.63 |
| STERIS (STE) | Ireland | $22.352B | 24.65 |
| Waters (WAT) | United States | $20.553B | 29.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.219B | 0.00 |
| Hologic (HOLX) | United States | $12.337B | 13.40 |
| Penumbra (PEN) | United States | $11.191B | 87.83 |
| Sysmex ADR (SSMXY) | Japan | $10.965B | 31.11 |
| Masimo (MASI) | United States | $8.304B | 30.63 |
| Globus Medical (GMED) | United States | $8.001B | 18.76 |
| Teleflex (TFX) | United States | $5.535B | 9.14 |
| Integer Holdings (ITGR) | United States | $4.173B | 21.87 |
| TransMedics (TMDX) | United States | $4.139B | 89.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.030B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.375B | 14.14 |
| Veracyte (VCYT) | United States | $2.231B | 31.31 |
| Nihon Kohden (NHNKY) | Japan | $2.050B | 23.51 |
| Elekta AB (EKTAY) | Sweden | $2.021B | 18.17 |
| Alphatec Holdings (ATEC) | United States | $1.862B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.522B | 0.00 |
| Artivion (AORT) | United States | $1.238B | 115.92 |
| Pulse Biosciences (PLSE) | United States | $1.097B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.004B | 5.34 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| SiBone (SIBN) | United States | $0.799B | 0.00 |
| IRadimed (IRMD) | United States | $0.660B | 33.49 |
| Mesa Laboratories (MLAB) | United States | $0.653B | 14.26 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.562B | 8.74 |
| Beta Bionics (BBNX) | United States | $0.557B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.555B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.539B | 0.00 |
| AxoGen (AXGN) | United States | $0.538B | 0.00 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| NeuroPace (NPCE) | United States | $0.512B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.467B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.363B | 9.66 |
| ClearPoint Neuro (CLPT) | United States | $0.348B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Neuronetics (STIM) | United States | $0.283B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.223B | 13.49 |
| Alpha Tau Medical (DRTS) | Israel | $0.199B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.167B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| Inogen (INGN) | United States | $0.158B | 0.00 |
| 908 Devices (MASS) | United States | $0.155B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.148B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.139B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.138B | 0.00 |
| CVRx (CVRX) | United States | $0.138B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.133B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.130B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 12.05 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.91 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |